Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-81,500
Closed -$45.8K 1421
2025
Q4
$45.8K Buy
81,500
+64,700
+385% +$67.6K ﹤0.01% 2286
2025
Q3
$24.4K Sell
16,800
-300
-2% -$536 ﹤0.01% 2293
2025
Q2
$31.1K Sell
17,100
-2,800
-14% -$6.07K ﹤0.01% 2277
2025
Q1
$44K Sell
19,900
-2,600
-12% -$9.54K ﹤0.01% 2328
2024
Q4
$93.2K Buy
22,500
+5,400
+32% +$16.3K ﹤0.01% 2226
2024
Q3
$29.1K Sell
17,100
-64,600
-79% -$109K ﹤0.01% 2239
2024
Q2
$136K Sell
81,700
-5,100
-6% -$18.8K ﹤0.01% 2282
2024
Q1
$950K Buy
86,800
+63,000
+265% +$377K ﹤0.01% 1608
2023
Q4
$87.3K Buy
23,800
+7,400
+45% +$18.7K ﹤0.01% 2340
2023
Q3
$50.5K Buy
16,400
+3,300
+25% +$15.1K ﹤0.01% 2275
2023
Q2
$62.5K Buy
+13,100
New +$72.4K ﹤0.01% 2253
2022
Q2
Sell
-11,800
Closed -$309K 2812
2022
Q1
$309K Buy
11,800
+100
+0.9% +$2.81K ﹤0.01% 2210
2021
Q4
$492K Sell
11,700
-51,800
-82% -$2.32M ﹤0.01% 1920
2021
Q3
$1.86M Buy
63,500
+1,200
+2% +$34.9K ﹤0.01% 1300
2021
Q2
$1.66M Buy
+62,300
New +$1.56M ﹤0.01% 1388

Other funds holding NOTV

Two Sigma Advisers's NOTV Position: Q1 2026 in Review

Two Sigma Advisers sold out of Inotiv (NOTV) in Q1 2026, closing a stake of 81,500 shares — an estimated $45.8K sold.

Two Sigma Advisers first reported a position in NOTV in Q2 2021 and held it in 15 quarters. The position peaked at $1.86M in Q3 2021. 50 funds tracked by Wall St. Rank hold NOTV as of Q1 2026.

  • Two Sigma Advisers reported no remaining Inotiv position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 81,500 Inotiv shares in Q1 2026, an estimated $45.8K.
  • Two Sigma Advisers first reported a position in Inotiv in Q2 2021 and held it in 15 quarters.
  • Two Sigma Advisers's Inotiv position peaked at $1.86M in Q3 2021.
  • 50 funds tracked by Wall St. Rank held Inotiv as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.